News

• CRF Fellows Course Connect Will Take Place Online May 7-9, 2021
• David J. Cohen, MD, MSc, Joins CRF as Director of Clinical and Outcomes Research and St. Francis Hospital as Director of Academic Affairs
• Free Access to TCT Connect Extended for One Year
• CTO 2021 Is Now an Online Event: CTO Connect
• Dr. Juan Granada Discusses COVID-19 and the Heart on ManoPod
• Randomized Clinical Trial Finds No Mortality Risk or Benefit Associated with Drug-Coated Devices in the Treatment of Peripheral Artery Disease
• Randomized Trial Reports Outcomes with Novel, Low Profile Fixed-Wire Drug-Eluting Stent that Facilitates Transradial Access
• Randomized Trial Comparing a Nano-Coated Coronary Stent and Shorter DAPT Did Not Meet Non-Inferiority Criteria for Thrombotic Events
• Randomized Trial Finds that Drug-Eluting Stents With Durable Polymers are Non-Inferior to Those With Biodegradable Polymers
• OnSight Medical Wins TCT Connect 2020 hark Tank Innovation Competition
• Deferral of PCI in FFR-Abnormal Lesions with Preserved Coronary Flow Reserve Is Not Associated with Similar Outcomes as Untreated Lesions with Normal FFR
• Physiology-guided Percutaneous Coronary Intervention Optimization Strategy May Lead to Improved Outcomes
• Fractional Flow Reserve Derived from Computed Tomography Coronary Angiography Did Not Significantly Reduce Costs But Reduced Rates of Invasive Coronary Angiography
• Trial Finds that Interventional Closure of Residual Atrial Septal Defect One-Month Post Transcatheter Mitral Valve Repair Was Not Superior to Medical Treatment
• Randomized Trial Studies Device Designed to Reduce Embolic Events in Patients Undergoing TAVR
• New Bioprosthetic Valve for TAVR Fails to Demonstrate Non-Inferiority
• Meta-Analysis of Bivalirudin vs. Heparin in Patients with MI Examines Mortality and Bleeding Rates
• Combined FFR and OCT Imaging Can Improve Accuracy of High-Risk Lesion Identification in Patients with Diabetes
• Pilot Randomized Trial Demonstrates that PCI of Non-Flow-Limiting Vulnerable Plaques May be Safe with Favorable Long-Term Clinical Outcomes
• NIRS-IVUS Imaging Can Help Identify High-Risk Plaques That Can Lead to Adverse Outcomes